bioMerieux acquired BioFire Diagnostics (formerly Idaho Technology) for $450 million plus approximately $35 million in net debt (EUR 355 million total). BioFire's FilmArray multiplex PCR system, which integrates sample preparation, amplification, detection and analysis into one device, became a cornerstone of bioMerieux's syndromic diagnostics strategy.